Clinic Diagnostic Disease Pharmaceutical 
Imaging Technology
MAY 25, 2023
Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. In the U.S., FES PET, like FDG PET, is now included in the NCCN Guidelines. The NCCN is a not-for-profit alliance of 33 leading U.S.
Imaging Technology
JUNE 21, 2024
milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MediView XR Inc., Proceduralists must refer to standard of care imaging and prioritize clinical experience and/or judgment when using the OmnifyXR system.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
JULY 25, 2024
a clinical-stage biotech developing groundbreaking secretome therapeutics for age and disease-related immune dysfunction, has announced a partnership with Springbok Analytics , a life sciences muscle analytics company. christine.book Thu, 07/25/2024 - 12:44 July 25, 2024 — Immunis, Inc. ,
AuntMinnie
JUNE 14, 2024
For those unfamiliar with steatotic liver disease, this is important because Rezdiffra is the first approved treatment for MASH, which if left untreated can progress to cirrhosis, require liver transplantation, and potentially cause death. Rajarshi Banerjee, MD, PhD.
Imaging Technology
FEBRUARY 12, 2024
The digital pathology solution was cleared for the purpose of primary diagnosis, reported the company, adding that it is cleared (K230839) for clinical use with the Hamamatsu NanoZoomer S360MD Slide scanner in the United States. Up to 70% of clinical decisions depend on pathology 1. Reference: 1. NHS England (2017).
Imaging Technology
JANUARY 8, 2024
Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.
Imaging Technology
NOVEMBER 20, 2023
NeuroShield is currently in clinical use in over 220+ sites across the world. In-Med is supported by seed funding from Sriram Natarajan, Founder & CEO of Molbio Diagnostics. Role of Volumetric Analysis in Correlation of Gender and Atrophy in Dementia in Clinical Practice. References: [i] JOSHI, J. Kulkarni, A.
Expert insights. Personalized for you.
94 
Let's personalize your content